Efficacy of Sputnik V was measured based on data from more than 1.2 million people vaccinated with two components of the vaccine between January and September 2021

MOSCOW, Nov 17 (The CONNECT) – The Russian Sputnik V coronavirus vaccine has demonstrated 96.3% efficacy and high safety profile, a new study of vaccinated individuals in the Republic of Belarus shows.

Belarus was the first foreign country to register Sputnik V and use it for vaccination of the population.

The Russian Direct Investment Fund (RDIF) and partners have facilitated the technology transfer to localize the production of Sputnik V by Belarus’s Belmedpreparaty company, which is successfully manufacturing Sputnik V. In April 2021 the vaccine produced in Belarus was authorized by the Ministry of Health.

In April 2021 the single-dose Sputnik Light vaccine (the first component of Sputnik V based on human adenovirus serotype 26) was also registered in Belarus.

RDIF said that an article analyzing efficacy of Sputnik V vaccine against coronavirus during vaccination campaign in Belarus has been published on the medRxiv preprint server for health sciences at:

https://www.medrxiv.org/content/10.1101/2021.11.15.21265526v1

Efficacy of Sputnik V was measured based on data from more than 1.2 million people vaccinated with two components of the vaccine between January and September 2021. High efficacy of Sputnik V is confirmed on the background of Delta variant being prevailing in Belarus since July 2021.

The study also confirmed high safety profile of Sputnik V -mild or moderate adverse events following vaccination and no deaths related to the vaccination.

New data complements previous data on high efficacy and safety of Sputnik V during vaccination campaign in Belarus between January and July 2021 showing the Russian vaccine has demonstrated 97.2% efficacy against coronavirus based on data from more than 860,000 people.  

RDIF is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling RUB 2.1 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn.